一位新西兰妇女对乳癌的无声诊断强调,需要筛查和获得救命药物。 A New Zealand woman’s silent breast cancer diagnosis stresses the need for screening and access to life-saving drugs.

Rotorua母亲在常规乳房X光检查中进行的无症状乳腺癌诊断强调了在新西兰进行筛查的重要性。 A Rotorua mother's asymptomatic breast cancer diagnosis during a routine mammogram underscores the importance of screening in New Zealand. 该案例突出了NZ和Wai Ariki乳腺癌基金会为提高认识和筹集资金所作的努力。 The case highlights efforts by the Breast Cancer Foundation NZ and Wai Ariki to boost awareness and funding. Pharmac正在审查Kisqali(ribociclib)的潜在供资情况,该药物证明可以减少高危早期病人的复发,全球研究表明,它可以防止数百人患上不治之症。 Pharmac is reviewing potential funding for Kisqali (ribociclib), a drug shown to reduce recurrence in high-risk early-stage patients, with global studies indicating it could prevent hundreds from progressing to incurable disease. 虽然澳大利亚已经提供获得服务的机会,但新西兰的决定取决于临床咨询、预算的可用性和相互竞争的优先事项,而且没有规定时间表。 While Australia already provides access, New Zealand’s decision hinges on clinical advice, budget availability, and competing priorities, with no timeline set.